Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of CBLL is 27 and suggests 33% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell